Trabectedin Synthesis via Selective Hydroxyl Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing trabectedin, a marine-derived anti-tumor drug, face challenges such as low yield, cumbersome synthesis routes, poor selectivity in protection and deprotection of hydroxyl groups, and the use of expensive and hazardous reagents, making them unsuitable for industrial production.
Innovation Solution
A method involving the selective protection and deprotection of hydroxyl groups using specific protecting agents like MOM and MEM, followed by oxidation and esterification steps, which improves reaction selectivity and simplifies purification, reducing the need for hazardous materials and complex chromatographic purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If biological extraction method is used to prepare trabectedin, then the preparation process is simple, but the yield is very low (0.0001%) and cannot satisfy industrial use
Solution Approach 1:
The patent applies preliminary action by performing selective protection of the primary hydroxyl group with TBDPS before subsequent oxidation and esterification steps. This pre-protection strategy prevents side reactions and enables high-yield transformation (88-95% per step) of the intermediate compounds, ultimately achieving industrial-scale production capability
Solution Approach 2:
The synthesis route is segmented into distinct modular steps: (1) selective protection of primary hydroxyl with TBDPS, (2) oxidation of phenol hydroxyl, (3) selective hydroxylation, (4) esterification with cysteic acid derivative. Each segment achieves high yield and can be independently optimized, transforming the overall productivity from 0.0001% to over 10%
2Productivity
If total synthesis method with 36 steps is used, then trabectedin can be synthesized, but the steps are cumbersome and require expensive chiral ligands and noble metal ruthenium
Solution Approach 1:
The patent uses preliminary action by pre-protecting the primary hydroxyl group with TBDPS before oxidation. This prevents the need for multiple protection/deprotection cycles and eliminates the requirement for expensive chiral ligands and noble metal catalysts, reducing the synthesis to fewer steps with higher yields (88-95% per step)
Solution Approach 2:
The patent replaces expensive noble metal ruthenium catalysts and chiral ligands with cheaper, non-noble metal reagents and catalysts. The TBDPS protecting group and standard oxidation reagents are used instead of complex chiral catalyst systems, making the process economically viable for industrial production
3Ease of operation
If protection and deprotection of phenol hydroxyl and primary hydroxyl groups is performed, then the reactions can proceed, but the selectivity is poor and purification is difficult
Solution Approach 1:
The patent applies local quality by selectively protecting only the primary hydroxyl group with TBDPS, leaving the phenol hydroxyl group unprotected. This localized protection strategy exploits the different reactivity of primary vs. phenolic hydroxyls, achieving high selectivity (95% purity) and easy purification without affecting reaction feasibility
Solution Approach 2:
The selective TBDPS protection is performed as a preliminary action before oxidation. This pre-establishes the correct molecular architecture and prevents side reactions, ensuring high manufacturing precision (95% purity) while maintaining operational ease through simplified workup procedures
4Productivity
If TBDPS protecting group is removed from compound 32/33, then compound 34 can be prepared, but MEM on phenol hydroxyl is easily removed simultaneously and by-products are difficult to remove
Solution Approach 1:
The patent uses local quality by selectively protecting only the primary hydroxyl with TBDPS and leaving the phenol hydroxyl unprotected. This prevents the simultaneous deprotection problem and eliminates difficult-to-remove by-products, achieving 95% purity and high preparation efficiency (88-95% yield per step)
Solution Approach 2:
The patent extracts the problematic dual-protection strategy and replaces it with selective single-protection. By taking out the MEM protecting group from the phenol hydroxyl and using only TBDPS on the primary hydroxyl, the method eliminates the by-product formation issue and simplifies purification while maintaining high productivity
5Reliability
If multiple protection and deprotection steps are performed, then the reactions can be controlled, but the operation steps become cumbersome
Solution Approach 1:
The patent uses preliminary action by performing selective TBDPS protection of the primary hydroxyl group before oxidation. This single pre-protection step controls the subsequent reactions reliably without requiring multiple protection/deprotection cycles, reducing operation steps from 36 to fewer than 10 steps while maintaining reaction control
Solution Approach 2:
The patent merges the protection and oxidation steps into a streamlined sequence where TBDPS protection is combined with subsequent oxidation and esterification in an integrated pathway. This reduces the number of operation steps while maintaining reliability through the selective nature of each transformation (88-95% yield per step)
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high conversion efficiency and purity of intermediates, significantly increasing the overall yield of trabectedin and simplifying the production process, making it more suitable for industrial applications.
Implementation Method 1
reacting compound QT10 with a hydroxyl protecting agent to obtain compound QT9
Implementation Method 2
subjecting the phenol hydroxyl group of compound QT8 to oxidization
Data Source
AI summary
The present invention provides a method for preparing an ecteinascidin compound and an intermediate thereof, and specifically provides a preparation method for a novel compound QT9, and a method of using QT9 to prepare an ecteinascidin compound. The method provided by the present invention has high reaction selectivity and high yield, the obtained compound is easy to purify, and defects in the prior art that multiple intermediates are oily substances, and the reaction selectivity is poor are solved. The method of the present invention is particularly applicable to industrial production.